Royalty Pharma (RPRX) Shares Outstanding (2020 - 2026)

Royalty Pharma has reported Shares Outstanding (Entity) for 7 years, with the latest figure at $443.6 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 4.24% year-over-year to $443.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $443.6 million (up 4.24% YoY) and the FY2025 annual result came in at $428.7 million, down 3.88% from the prior year.
• Shares Outstanding (Entity) climbed to $443.6 million in Q1 2026 per RPRX's latest filing, from $428.7 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $451.0 million in Q1 2024 and troughed at $425.6 million in Q1 2025.
• A 5-year average of $441.1 million and a median of $443.6 million in 2026 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) increased 10.81% in 2022, then slipped 5.63% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $443.2 million in 2022, then advanced by 0.8% to $446.7 million in 2023, then declined by 0.16% to $446.0 million in 2024, then retreated by 3.88% to $428.7 million in 2025, then grew by 3.49% to $443.6 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $443.6 million, $428.7 million, and $429.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.